CN1097741A - 吡啶衍生物、其制备方法和用途 - Google Patents

吡啶衍生物、其制备方法和用途 Download PDF

Info

Publication number
CN1097741A
CN1097741A CN94105244A CN94105244A CN1097741A CN 1097741 A CN1097741 A CN 1097741A CN 94105244 A CN94105244 A CN 94105244A CN 94105244 A CN94105244 A CN 94105244A CN 1097741 A CN1097741 A CN 1097741A
Authority
CN
China
Prior art keywords
alkyl
compound
halogen
alkoxy
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94105244A
Other languages
English (en)
Chinese (zh)
Inventor
白石充
渡边敏文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CN1097741A publication Critical patent/CN1097741A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN94105244A 1993-04-28 1994-04-28 吡啶衍生物、其制备方法和用途 Pending CN1097741A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP102880/93 1993-04-28
JP10288093 1993-04-28
JP5575694 1994-03-25
JP055756/94 1994-03-25

Publications (1)

Publication Number Publication Date
CN1097741A true CN1097741A (zh) 1995-01-25

Family

ID=26396653

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94105244A Pending CN1097741A (zh) 1993-04-28 1994-04-28 吡啶衍生物、其制备方法和用途

Country Status (11)

Country Link
US (1) US5716971A (enExample)
EP (1) EP0623597B1 (enExample)
CN (1) CN1097741A (enExample)
AT (1) ATE159520T1 (enExample)
AU (1) AU668026B2 (enExample)
CA (1) CA2122436A1 (enExample)
DE (1) DE69406350T2 (enExample)
FI (1) FI941963L (enExample)
HU (1) HUT70446A (enExample)
NO (1) NO941542L (enExample)
TW (1) TW266206B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
DE69701298T2 (de) * 1996-04-15 2000-10-05 Takeda Chemical Industries, Ltd. Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
CZ290178B6 (cs) 1999-07-22 2002-06-12 Sankyo Company Limited Deriváty cyklobutenu
KR20030026979A (ko) * 2000-07-18 2003-04-03 야마노우치세이야쿠 가부시키가이샤 디시아노피리딘 유도체를 포함하는 의약
WO2003033471A1 (en) * 2001-10-17 2003-04-24 Tobishi Pharmaceutical Co.,Ltd Novel pyridone derivative and remedial agent for circulatory disease containing the same
PT3762368T (pt) 2018-03-08 2022-05-06 Incyte Corp Compostos de aminopirazina diol como inibidores de pi3k-y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH350461A (de) * 1957-12-06 1960-11-30 Ciba Geigy Verwendung von Oxyketonen zum Schutze gegen ultraviolette Strahlung
JPS49119718A (enExample) * 1973-03-23 1974-11-15
CH609980A5 (en) * 1974-08-30 1979-03-30 Ciba Geigy Ag Process for the preparation of novel piperidine derivatives
US4297359A (en) * 1978-07-25 1981-10-27 Acf Chemiefarma Nv Anti-ulcer compositions containing certain pyridyl oxime ethers
JPS5855186B2 (ja) * 1981-07-31 1983-12-08 保土谷化学工業株式会社 色素の製造法
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
JP2765876B2 (ja) * 1988-10-24 1998-06-18 科研製薬株式会社 ピリジルケトオキシムエーテル誘導体
EP0388682A1 (de) * 1989-03-15 1990-09-26 Bayer Ag Substituierte Heteroarylphenylether, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
FR2644456B1 (fr) * 1989-03-17 1991-07-05 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0983992B1 (en) * 1992-04-22 2005-10-26 Ligand Pharmaceuticals Incorporated Compounds having selectivity for retinoid x receptors

Also Published As

Publication number Publication date
FI941963A0 (fi) 1994-04-28
DE69406350D1 (de) 1997-11-27
AU668026B2 (en) 1996-04-18
AU6063394A (en) 1994-11-03
NO941542D0 (enExample) 1994-04-27
FI941963A7 (fi) 1994-10-29
NO941542L (no) 1994-10-31
CA2122436A1 (en) 1994-10-29
HUT70446A (en) 1995-10-30
EP0623597B1 (en) 1997-10-22
EP0623597A1 (en) 1994-11-09
DE69406350T2 (de) 1998-06-04
US5716971A (en) 1998-02-10
FI941963L (fi) 1994-10-29
TW266206B (enExample) 1995-12-21
HU9401214D0 (en) 1994-08-29
ATE159520T1 (de) 1997-11-15

Similar Documents

Publication Publication Date Title
CN1254335A (zh) 烟酰胺衍生物
CN1085663C (zh) 作为解痛剂的芳族氨基醚
CN1118595A (zh) 氨茴酸衍生物
CN1304406A (zh) 作为玻连蛋白拮抗剂的杂环甘氨酰β-丙氨酸衍生物
CN1169792C (zh) 取代的乙烯基吡啶衍生物和含有它们的药物
CN1681507A (zh) 新的螺稠合喹唑酮和它们作为磷酸二酯酶抑制剂的用途
TW200938529A (en) Compounds
CN1267281A (zh) 胰高血糖素拮抗剂/反向激动剂
CN1159804A (zh) 二氢苯并呋喃
CN1171394A (zh) 新的脲衍生物及其制法和医药用途
CN1867551A (zh) 作为前列腺素e2拮抗剂的苯基或吡啶基酰胺化合物
CN1395566A (zh) 促肾上腺皮质激素释放因子拮抗剂
CN101061106A (zh) 谷氨酸受体增效剂
CN1285834A (zh) 稠合吡嗪化合物
CN1246857A (zh) 取代的嘧啶酮和吡啶酮化合物和它们的应用
CN1856476A (zh) 异喹啉酮钾通道抑制剂
CN1033325C (zh) 抗炎异羟肟酸和n-羟基脲的制备方法
CN1960977A (zh) 喹唑啉衍生物
CN1678320A (zh) N-联芳基甲基氨基环烷酰胺衍生物
CN1922170A (zh) 新的羟基-6-杂芳基菲啶及其作为pde4
CN1856477A (zh) 异喹啉钾通道抑制剂
CN1299282A (zh) 玻连蛋白受体拮抗剂
CN1060467A (zh) 1,3-苯并嗪衍生物、其生产方法和用途
CN1097741A (zh) 吡啶衍生物、其制备方法和用途
CN1671668A (zh) 4-取代芳基-5-羟基异喹啉酮衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication